Arcus Biosciences, Inc. Major Shareholders & Ownership History
Major Shareholder Name | Reporting Date | Shares Held | Market Value | Change in Shares | Ownership |
---|---|---|---|---|---|
GILEAD SCIENCES, INC. | 02/13/2025 | 30.06 M | $447.61 M | 100.00% | 32.89% |
BLACKROCK, INC. | 02/07/2025 | 9.69 M | $144.35 M | -0.39% | 10.61% |
VANGUARD GROUP INC | 02/11/2025 | 5.39 M | $80.25 M | -1.45% | 5.90% |
FMR LLC | 02/13/2025 | 4.05 M | $60.34 M | -9.29% | 4.43% |
WOODLINE PARTNERS LP | 02/14/2025 | 3.52 M | $52.47 M | 1.31% | 3.86% |
STATE STREET CORP | 02/14/2025 | 2.99 M | $44.58 M | -0.58% | 3.28% |
POINT72 ASSET MANAGEMENT, L.P. | 02/14/2025 | 2.00 M | $29.72 M | -18.09% | 2.18% |
DIMENSIONAL FUND ADVISORS LP | 02/13/2025 | 1.70 M | $25.35 M | 11.70% | 1.86% |
SIREN, L.L.C. | 02/14/2025 | 1.61 M | $24.00 M | 0.00% | 1.76% |
02/14/2025 | 1.60 M | $23.86 M | 100.00% | 1.75% | |
AMERIPRISE FINANCIAL INC | 02/14/2025 | 1.55 M | $23.04 M | 17.31% | 1.69% |
BNP PARIBAS ASSET MANAGEMENT HOLDING S.A. | 02/12/2025 | 1.52 M | $22.66 M | 63.45% | 1.67% |
PARKMAN HEALTHCARE PARTNERS LLC | 02/14/2025 | 1.27 M | $18.97 M | 24.18% | 1.39% |
GEODE CAPITAL MANAGEMENT, LLC | 02/12/2025 | 1.21 M | $18.02 M | -1.03% | 1.32% |
MILLENNIUM MANAGEMENT LLC | 02/14/2025 | 924.37 K | $13.76 M | 277.14% | 1.01% |
DECHENG CAPITAL LLC | 02/14/2025 | 808.79 K | $12.04 M | -7.01% | 0.88% |
BRAIDWELL LP | 02/14/2025 | 802.10 K | $11.94 M | 100.00% | 0.88% |
CHARLES SCHWAB INVESTMENT MANAGEMENT INC | 02/06/2025 | 579.62 K | $8.63 M | 2.23% | 0.63% |
SUVRETTA CAPITAL MANAGEMENT, LLC | 02/14/2025 | 576.16 K | $8.58 M | -13.18% | 0.63% |
MORGAN STANLEY | 02/14/2025 | 549.91 K | $8.19 M | -23.03% | 0.60% |
NORTHERN TRUST CORP | 02/14/2025 | 532.10 K | $7.92 M | 4.35% | 0.58% |
JACOBS LEVY EQUITY MANAGEMENT, INC | 02/14/2025 | 465.30 K | $6.93 M | 100.00% | 0.51% |
GOLDMAN SACHS GROUP INC | 02/11/2025 | 443.45 K | $6.60 M | -36.95% | 0.49% |
ADAGE CAPITAL PARTNERS GP, L.L.C. | 02/14/2025 | 443.00 K | $6.60 M | 100.00% | 0.48% |
BANK OF NEW YORK MELLON CORP | 02/04/2025 | 381.62 K | $5.68 M | 8.62% | 0.42% |
MACQUARIE GROUP LTD | 02/14/2025 | 379.10 K | $5.65 M | 0.00% | 0.41% |
IKARIAN CAPITAL, LLC | 02/14/2025 | 378.36 K | $5.63 M | -49.14% | 0.41% |
CITADEL ADVISORS LLC | 02/14/2025 | 360.59 K | $5.37 M | 13.44% | 0.39% |
READYSTATE ASSET MANAGEMENT LP | 02/14/2025 | 351.36 K | $5.23 M | 100.00% | 0.38% |
GRANAHAN INVESTMENT MANAGEMENT, LLC | 02/14/2025 | 346.09 K | $5.15 M | -3.28% | 0.38% |
TREXQUANT INVESTMENT LP | 02/12/2025 | 300.55 K | $4.48 M | 241.55% | 0.33% |
PRINCIPAL FINANCIAL GROUP INC | 01/31/2025 | 263.52 K | $3.92 M | 3.09% | 0.29% |
DAFNA CAPITAL MANAGEMENT LLC | 02/14/2025 | 254.22 K | $3.79 M | -0.97% | 0.28% |
AXA S.A. | 02/14/2025 | 231.90 K | $3.45 M | -0.16% | 0.25% |
CUBIST SYSTEMATIC STRATEGIES, LLC | 02/14/2025 | 225.17 K | $3.35 M | 220.33% | 0.25% |
NORDEA INVESTMENT MANAGEMENT AB | 01/06/2025 | 218.93 K | $3.24 M | 2.46% | 0.24% |
INVESCO LTD. | 02/13/2025 | 203.99 K | $3.04 M | 21.36% | 0.22% |
JANE STREET GROUP, LLC | 02/14/2025 | 202.50 K | $3.02 M | -6.70% | 0.22% |
ALGERT GLOBAL LLC | 02/14/2025 | 180.12 K | $2.68 M | 59.62% | 0.20% |
HUDSON BAY CAPITAL MANAGEMENT LP | 02/14/2025 | 170.00 K | $2.53 M | -2.86% | 0.19% |
02/14/2025 | 165.97 K | $2.47 M | 100.00% | 0.18% | |
BANK OF AMERICA CORP /DE/ | 02/14/2025 | 160.15 K | $2.38 M | 13.65% | 0.18% |
RHUMBLINE ADVISERS | 01/30/2025 | 159.26 K | $2.37 M | -1.59% | 0.17% |
PLATINUM INVESTMENT MANAGEMENT LTD | 02/11/2025 | 153.78 K | $2.29 M | 0.00% | 0.17% |
LEGAL & GENERAL GROUP PLC | 02/13/2025 | 149.21 K | $2.22 M | 1.52% | 0.16% |
TWO SIGMA INVESTMENTS, LP | 02/14/2025 | 146.69 K | $2.18 M | 8.13% | 0.16% |
IKARIAN CAPITAL, LLC | 02/14/2025 | 141.00 K | $2.10 M | 24.01% | 0.15% |
PUBLIC SECTOR PENSION INVESTMENT BOARD | 02/14/2025 | 135.03 K | $2.01 M | 18.03% | 0.15% |
SCHONFELD STRATEGIC ADVISORS LLC | 02/14/2025 | 135.00 K | $2.01 M | -79.97% | 0.15% |
NUVEEN ASSET MANAGEMENT, LLC | 02/14/2025 | 131.86 K | $1.96 M | -22.37% | 0.14% |
Arcus Biosciences, Inc. institutional Ownership - FAQ's
During the previous two years, 190 institutional investors and hedge funds held shares of Arcus Biosciences, Inc.. The most heavily invested institutionals were:
Asset Dedication, LLC: 0
Farther Finance Advisors, LLC: 0
SIGNATUREFD, LLC: 0
MASSMUTUAL TRUST CO FSB/ADV: 0
Ronald Blue Trust, Inc.: 0
GILEAD SCIENCES, INC.: 30.06 M
91.80% of Arcus Biosciences, Inc. stock is owned by institutional investors.
Institutional investors have bought a total of 86.27 M shares in the last 24 months. This purchase volume represents approximately $786.81 M in transactions.